-
Multinational pharmaceutical companies set off a wave of rare disease mergers and acquisitions, domestic pharmaceutical companies take orphan drugs to go to sea, Ascentage, Shiyao, Junshi
Time of Update: 2022-12-30
First, there are about 300 million patients with rare diseases in the world, and there are huge commercial interests in the market Due to the significant characteristics of small patient population, difficult drug research and development, and high cost, the rare disease track has always been a well-known "unpopular" and niche track, unlike anti-tumor, autoimmune and other popular tracks, attracting many pharmaceutical companies to compete and fight fiercely.
-
China's 5G breakthrough in wireless transmission core technology
Time of Update: 2022-11-22
The main technical objectives of the first phase of the 5G major project include: research on key technologies such as 5G network system architecture, wireless networking, wireless transmission, new antennas and radio frequencies, and new spectrum development and utilization, complete performance evaluation and prototype system design, carry out wireless transmission technology tests, support the total service rate of 10Gbps, and improve the spectrum efficiency and power efficiency of the air interface by 10 times compared with 4G.
-
Professor Wang Xiaojia: Learn from the past, and see how Giredestrant is changing the treatment landscape of HR-positive breast cancer
Time of Update: 2022-10-26
Fig. 2 Changes in ER/PgR protein levels in week 2 of coopERA biomarker subgroup analysis Fig. 3 Results of ER activity score changes in coopERA biomarker subgroup analysisThe acelERA study is a phase II study comparing Giredestrant with physician-selected endocrine monotherapy in patients with previously treated ER+/HER2– locally advanced or metastatic breast cancer (LA/mBC).
-
Dawn shares raised 700 million for 120,000 tons of PBAT and other projects
Time of Update: 2022-09-17
, Ltd. issued an announcement that the company plans to raise funds of no more than 770 million yuan through non-public offerings, which will be used to invest in the construction of a new project of fully biodegradable plastics (PBAT) (Phase I), Southwest Headquarters Base Project (Phase I) and supplementary Liquidity .
-
Shenzhen Advanced Institute and others found that graphene can be used to efficiently recover gold resources from e-waste
Time of Update: 2022-08-31
Figure 1 Schematic diagram of graphene extraction of gold Figure 2 (a) Graphene dispersion (left) and graphene film (right); (b) schematic diagram of continuous adsorption of trace gold based on graphene film and (c) adsorption efficiency; (d) graphene from electronic waste Schematic diagram of the process of recovering gold Gold is widely used as a good conductor of electricity in the fields of electronic products and consumer goods .
-
Collagen plays a key role in breast cancer metastasis
Time of Update: 2022-08-20
A team of scientists led by Associate Professor Thomas Cox, head of the Matrix and Metastasis Laboratory, also found that high levels of collagen twelfth can trigger the spread of breast cancer cells from the tumor to other parts of the body, which A process is called transfer .
-
How coronaviruses exploit the host's antiviral defenses to replicate efficiently
Time of Update: 2022-08-19
Nature, 2022 backgroundAfter the ribonucleic acid (RNA) of the coronavirus enters the host cell, it triggers the infected cell to secrete interferon, which inhibits the replication of the virus in the infected cell and reduces the risk of infection among other uninfected cells .
-
Wang Yiguang's research team from the School of Pharmacy develops a new generation of pH ultra-sensitive nano-delivery technology
Time of Update: 2022-04-27
Due to the positive synergistic effect of the self-assembly of amphiphilic nanomaterials, the nano-assembly system of pH-sensitive polymers exhibits significantly better pH-response precision and tunability than general small-molecule probes, with diverse chemical structures and high signal contrast.
-
The research results of camrelizumab in the field of esophageal cancer - the press conference on the second-line CAP 02 study of advanced esophageal cancer was successfully held
Time of Update: 2022-02-22
In January 2022, a multi-center phase II clinical study (CAP 02 study) of camrelizumab combined with apatinib in the second-line treatment of advanced esophageal squamous cell carcinoma, led by Prof.
-
The first Alzheimer's disease vaccine entered clinical trials in 20 years
Time of Update: 2021-12-06
ArticleMedicine GuanlanUS time on November 16, news, Brigham and Women's Hospital (Brigham and Women's Hospital) announced that it will start a phase 1 clinical trial to evaluate a new nasal vaccine in preventing and slowing the progression of Alzheimer's disease (AD) The safety and effectiveness .
-
Changes in the proteome of resistant wheat infected by pathogenic bacteria revealed
Time of Update: 2021-11-12
Further analysis revealed that the expression trends of 33 proteins related to defense, cell wall formation and photosynthesis were significantly different between resistant and susceptible varieties at multiple time points after inoculation .
-
The performance of the chemical sub-sectors climbs, the coatings market has improved
Time of Update: 2021-11-06
Industry analysts said that sub-sectors such as potash fertilizer and disperse dyes are expected to usher in both performance and valuation, driven by better demand and lower costs.
-
Nature: The composition and function of the intestinal flora may affect the susceptibility to konzo
Time of Update: 2021-09-19
Eric Vilain, MD, director of the National Children’s Genetic Medicine Research Center, said: “Knowing who is at greater risk can lead to targeted interventions, better handling of cassava, or trying a diversified diet .
-
To protect scientists is to protect scientific research productivity
Time of Update: 2021-09-03
As an important breakthrough for promoting the development of science and technology and stimulating the innovative vitality of scientific research personnel, the reform of scientific research funding management must be able to loosen the constraints on the hands and feet of scientific researchers, and allow funds to serve the scientific research activities themselves, rather than becoming a burden .
-
CDE: Publicly solicit opinions on the guiding principles of 17 varieties
Time of Update: 2021-07-28
Transfer from: CDE Editor: Dandelion-Green Tea On April 12-13, CDE issued 6 notices to solicit opinions on guiding principles . The time limit for soliciting opinions is 1 month from the date of p
